CN219590235U - Blood glucose uric acid test paper with red blood cell packed volume correction function - Google Patents
Blood glucose uric acid test paper with red blood cell packed volume correction function Download PDFInfo
- Publication number
- CN219590235U CN219590235U CN202320142978.6U CN202320142978U CN219590235U CN 219590235 U CN219590235 U CN 219590235U CN 202320142978 U CN202320142978 U CN 202320142978U CN 219590235 U CN219590235 U CN 219590235U
- Authority
- CN
- China
- Prior art keywords
- layer
- electrode
- uric acid
- blood glucose
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 98
- 239000008280 blood Substances 0.000 title claims abstract description 98
- 238000012360 testing method Methods 0.000 title claims abstract description 38
- 238000012937 correction Methods 0.000 title claims abstract description 17
- YJJZLQRYDADJRV-BTVCFUMJSA-N 7,9-dihydro-3h-purine-2,6,8-trione;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.N1C(=O)NC(=O)C2=C1NC(=O)N2 YJJZLQRYDADJRV-BTVCFUMJSA-N 0.000 title claims abstract description 10
- 210000003743 erythrocyte Anatomy 0.000 title claims abstract 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims abstract description 56
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims abstract description 56
- 229940116269 uric acid Drugs 0.000 claims abstract description 56
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 51
- 239000008103 glucose Substances 0.000 claims abstract description 51
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 39
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 39
- 108090000790 Enzymes Proteins 0.000 claims abstract description 35
- 102000004190 Enzymes Human genes 0.000 claims abstract description 35
- 238000005534 hematocrit Methods 0.000 claims abstract description 30
- 108010092464 Urate Oxidase Proteins 0.000 claims abstract description 20
- 229910021607 Silver chloride Inorganic materials 0.000 claims abstract description 14
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims abstract description 14
- 239000000758 substrate Substances 0.000 claims abstract description 12
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910052709 silver Inorganic materials 0.000 claims abstract description 7
- 239000004332 silver Substances 0.000 claims abstract description 7
- 238000009825 accumulation Methods 0.000 claims abstract 3
- 239000010410 layer Substances 0.000 claims description 121
- 239000003292 glue Substances 0.000 claims description 8
- 239000012790 adhesive layer Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims 1
- 238000005259 measurement Methods 0.000 abstract description 15
- 238000001514 detection method Methods 0.000 abstract description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000003487 electrochemical reaction Methods 0.000 description 4
- 239000000306 component Substances 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000000840 electrochemical analysis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- FHCPAXDKURNIOZ-UHFFFAOYSA-N tetrathiafulvalene Chemical compound S1C=CSC1=C1SC=CS1 FHCPAXDKURNIOZ-UHFFFAOYSA-N 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical group [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- 238000013100 final test Methods 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
技术领域technical field
本实用新型涉及血糖尿酸测试纸,特别是一种具有红细胞压积校正功能的血糖尿酸测试纸。The utility model relates to a blood sugar and uric acid test paper, in particular to a blood sugar and uric acid test paper with a hematocrit correction function.
背景技术Background technique
糖尿病是危害人类健康的主要代谢疾病之一,其症状主要表现为血液和尿液中葡萄糖含量的异常。同时,随着生活水平的不断提升和人们生活方式的逐渐改变,高尿酸人群的数量日益增多。高尿酸和高血糖一样都属于代谢类疾病,彼此之间相互影响。据研究发现,血液尿酸水平,每增高60μmol/L,糖尿病发生的风险就会增加百分之18%。因此,检测血液中血糖、尿酸的含量对慢性病的预防和诊断具有非常重要的意义。Diabetes is one of the major metabolic diseases that endanger human health, and its symptoms are mainly manifested as abnormal glucose levels in blood and urine. At the same time, with the continuous improvement of living standards and the gradual changes in people's lifestyles, the number of people with high uric acid is increasing. Both high uric acid and high blood sugar are metabolic diseases and affect each other. According to research, for every 60 μmol/L increase in blood uric acid level, the risk of diabetes will increase by 18%. Therefore, detecting the content of blood sugar and uric acid in the blood is of great significance to the prevention and diagnosis of chronic diseases.
目前在市场上单功能血糖试条、尿酸试条较为普遍,这些试条上大多只有单一反应区,只能检测单项指标。若想要进行多组分检测,需要多次重复进样来实现,给用户在使用过程中带来诸多不便,并且消耗大量试纸。而多功能试条技术能完美解决以上问题,节省采血量,简化操作步骤。比如:中国实用新型专利(CN 209086198 U)公布了一种血糖、尿酸双功能电化学试条,通过在第一冲孔和第二冲孔内覆盖与尿酸反应的第一酶层及与血糖反应的第二酶层,实现同时检测血糖和尿酸,使用者无需每次测试更换设备,用户使用更加便捷。At present, single-function blood glucose test strips and uric acid test strips are relatively common in the market. Most of these test strips only have a single reaction zone and can only detect a single indicator. If you want to perform multi-component detection, you need to repeat the sample injection many times to achieve it, which brings a lot of inconvenience to the user during use and consumes a lot of test paper. The multi-functional test strip technology can perfectly solve the above problems, save the amount of blood collected, and simplify the operation steps. For example: Chinese utility model patent (CN 209086198 U) has announced a kind of blood sugar, uric acid dual-functional electrochemical test strip, by covering the first enzyme layer that reacts with uric acid and reacting with blood sugar in the first punching hole and the second punching hole The second enzyme layer realizes the simultaneous detection of blood sugar and uric acid, and the user does not need to change the device for each test, which is more convenient for the user.
此外,对于血液中葡萄糖和尿酸浓度等血液成分的测定,由于测试值随着血细胞比容(以下称HCT)发生变化,会影响低压积或高压积人群最终测试结果的准确性。因此,为了得到准确可靠的检测结果,有必要进行HCT校正。比如:中国发明专利(CN1059736946A)公布了一种带红细胞压积测量和补偿的血糖试纸,通过测量HCT对血糖浓度测量值进行动态校准,从而提高了检测结果的准确度。中国专利(CN 10911583 A)公布了一种带红细胞压积补偿的高精度尿酸电化学试纸,利用HCT对血糖浓度的影响曲线对尿酸测量值进行补偿,将测量精度范围由常规的20%-50%扩大到了10%-70%,拓展了试纸适用范围。In addition, for the determination of blood components such as glucose and uric acid concentration in the blood, since the test value changes with the hematocrit (hereinafter referred to as HCT), it will affect the accuracy of the final test results for low-volume or high-volume populations. Therefore, in order to obtain accurate and reliable detection results, it is necessary to perform HCT correction. For example, the Chinese invention patent (CN1059736946A) discloses a blood glucose test paper with hematocrit measurement and compensation, which dynamically calibrates the measured value of blood glucose concentration by measuring HCT, thereby improving the accuracy of the detection results. Chinese patent (CN 10911583 A) discloses a high-precision uric acid electrochemical test paper with hematocrit compensation, which uses the HCT influence curve on blood sugar concentration to compensate the uric acid measurement value, and the measurement accuracy range is changed from conventional 20%-50 % expanded to 10%-70%, expanding the scope of application of test paper.
综上,开发出一种具有HCT校正功能并能同时测量血糖、尿酸且相互不干扰的电化学检测试纸,对于提高检测结果的准确度以及便于用户及时监测具有重要意义。In summary, the development of an electrochemical detection test strip with HCT correction function and the ability to simultaneously measure blood glucose and uric acid without interfering with each other is of great significance for improving the accuracy of test results and facilitating timely monitoring by users.
发明内容Contents of the invention
本实用新型所要解决的技术问题是,针对现有技术不足,提供一种具有红细胞压积校正功能的血糖尿酸测试纸,其目的在于,实现一张试纸同时测量血糖、尿酸两项指标,且试纸具备红细胞压积(HCT)校正功能,对血糖和尿酸测量结果分别进行校准,提高血糖和尿酸测量结果的准确度。The technical problem to be solved by the utility model is to provide a blood glucose and uric acid test paper with hematocrit correction function in view of the deficiencies in the prior art. With the hematocrit (HCT) correction function, the blood glucose and uric acid measurement results are calibrated separately to improve the accuracy of the blood glucose and uric acid measurement results.
为解决上述技术问题,本实用新型所采用的技术方案是:一种具有红细胞压积校正功能的血糖尿酸测试纸,包括从下至上设置的基板、电极层、酶层和亲水膜层,所述酶层包括尿酸酶层和血糖酶层,所述电极层包括由银浆层、第一碳层、氯化银电极、第二碳层及绝缘层,所述第一碳层包括形成电流回路的血糖对电极和血糖工作电极,所述血糖酶层覆盖于所述血糖对电极和所述血糖工作电极的上表面,所述第二碳层包括尿酸工作电极、第一电极及第二电极,所述尿酸酶层覆盖于形成电流回路的所述尿酸工作电极与所述氯化银电极的上表面,所述第一电极与所述第二电极之间形成电流回路。In order to solve the above-mentioned technical problems, the technical solution adopted by the utility model is: a blood glucose and uric acid test paper with hematocrit correction function, including a substrate, an electrode layer, an enzyme layer and a hydrophilic film layer arranged from bottom to top. The enzyme layer includes a uricase layer and a blood sugar enzyme layer, and the electrode layer includes a silver paste layer, a first carbon layer, a silver chloride electrode, a second carbon layer and an insulating layer, and the first carbon layer includes an electric current loop. The blood glucose counter electrode and the blood glucose working electrode, the blood glucose enzyme layer covers the upper surface of the blood glucose counter electrode and the blood glucose working electrode, the second carbon layer includes a uric acid working electrode, a first electrode and a second electrode, The uricase layer covers the upper surfaces of the uric acid working electrode and the silver chloride electrode forming a current loop, and a current loop is formed between the first electrode and the second electrode.
血糖对电极和血糖工作电极之间形成电流回路,用于测量血糖。所述尿酸工作电极与所述氯化银电极之间形成电流回路,用于测量尿酸。所述第一电极与所述第二电极之间形成电流回路,用于测量HCT阻抗值。A current loop is formed between the blood glucose counter electrode and the blood glucose working electrode for measuring blood glucose. A current loop is formed between the uric acid working electrode and the silver chloride electrode for measuring uric acid. A current loop is formed between the first electrode and the second electrode for measuring the HCT impedance value.
在本实用新型的一个优选的实施例中,所述第二碳层由掺杂有氧化型电子介体碳浆印刷而成。掺杂有氧化型电子介体碳浆可采用公开号为CN102507670B的中国专利中的碳浆,即本申请的第二碳层可采用公开号为CN102507670B的中国专利中的工作电极2。In a preferred embodiment of the present invention, the second carbon layer is printed from carbon paste doped with oxidized electron mediators. The carbon slurry doped with the oxidized electron mediator can be the carbon slurry in the Chinese patent publication number CN102507670B, that is, the second carbon layer of the present application can be the working electrode 2 in the Chinese patent publication number CN102507670B.
本实用新型将所述第二碳层设置为包括电子介体,所述的尿酸酶层不含电子介体。所述的尿酸酶层的酶层不含电子介体,经血液流动,其余尿酸组分不会干扰血糖回路电流。In the utility model, the second carbon layer is set to include electron mediators, and the uricase layer does not contain electron mediators. The enzyme layer of the uricase layer does not contain electron mediators, and the remaining uric acid components will not interfere with the blood sugar circuit current through blood flow.
在本实用新型的一个优选的实施例中,所述第二碳层的碳层厚度为10um~300um。In a preferred embodiment of the present invention, the thickness of the carbon layer of the second carbon layer is 10um-300um.
在本实用新型的一个优选的实施例中,所述电极层与所述亲水膜层之间通过胶层连接,所述胶层环绕所述酶层设置。In a preferred embodiment of the present invention, the electrode layer and the hydrophilic membrane layer are connected by a glue layer, and the glue layer is arranged around the enzyme layer.
在本实用新型的一个优选的实施例中,所述电极层上方、所述胶层、所述亲水膜层下方之间形成虹吸槽,所述尿酸酶层靠近所述虹吸槽的槽口外侧设置,所述血糖酶层远离所述虹吸槽的槽口设置,所述亲水膜层远离所述虹吸槽的槽口端部开设有虹吸孔。In a preferred embodiment of the present invention, a siphon groove is formed between the top of the electrode layer, the glue layer, and the bottom of the hydrophilic film layer, and the uricase layer is close to the outside of the notch of the siphon groove The glucose enzyme layer is arranged away from the notch of the siphon groove, and the end of the hydrophilic film layer far away from the notch of the siphon groove is provided with a siphon hole.
靠虹吸孔的虹吸作用力将血液吸入虹吸槽,使血液中的血糖和尿酸与不同的酶层反应产生电流,其中尿酸酶层不干扰血糖反应电流,血糖酶层不干扰尿酸反应电流。The blood is sucked into the siphon groove by the siphon force of the siphon hole, so that the blood sugar and uric acid in the blood react with different enzyme layers to generate current, in which the uricase layer does not interfere with the blood sugar reaction current, and the blood glucose enzyme layer does not interfere with the uric acid reaction current.
所述的尿酸酶层位于试纸前端,其酶层不含电子介体,经血液流动,其余尿酸组分不会干扰血糖回路电流。血糖酶层位于试纸最内侧,其酶层中的电子介体不会随着血液流动干扰尿酸回路电流,因此必须按照尿酸酶层在试纸前端,血糖酶层在试纸内侧这种顺序,实现一滴血即可同时测量血糖、尿酸两项指标,且试纸具备红细胞压积(HCT)校正功能。The uricase layer is located at the front end of the test paper, and the enzyme layer does not contain electron mediators, and the remaining uric acid components will not interfere with the blood sugar circuit current through blood flow. The blood glucose enzyme layer is located on the innermost side of the test paper, and the electron mediator in the enzyme layer will not interfere with the uric acid circuit current along with the blood flow. Therefore, it is necessary to follow the order of the uricase layer at the front of the test paper and the blood glucose enzyme layer on the inside of the test paper to achieve a drop of blood. It can simultaneously measure two indicators of blood sugar and uric acid, and the test strip has the function of correcting hematocrit (HCT).
在本实用新型的一个优选的实施例中,所述银浆层、所述第一碳层、所述氯化银电极、所述第二碳层及所述绝缘层依次从下至上印刷于所述基板的上表面。In a preferred embodiment of the present invention, the silver paste layer, the first carbon layer, the silver chloride electrode, the second carbon layer and the insulating layer are printed on the the upper surface of the substrate.
在本实用新型的一个优选的实施例中,所述胶层为双面胶层。In a preferred embodiment of the present utility model, the adhesive layer is a double-sided adhesive layer.
在本实用新型的一个优选的实施例中,所述基板为PET基板。In a preferred embodiment of the present invention, the substrate is a PET substrate.
与现有技术相比,本实用新型所具有的有益效果为:Compared with the prior art, the utility model has the beneficial effects as follows:
①首次实现一张试纸、一滴血液测量血糖、尿酸两项指标,同时试纸具备红细胞压积(HCT)校正功能,对血糖和尿酸测量结果分别进行校准,提高血糖和尿酸测量结果的准确度。① For the first time, one test strip and one drop of blood can be used to measure blood glucose and uric acid. At the same time, the test strip has the function of hematocrit (HCT) correction, which can calibrate the blood glucose and uric acid measurement results separately to improve the accuracy of the blood glucose and uric acid measurement results.
②尿酸电极利用掺杂技术与血糖电极组合,通过5道精密套位印刷形成独特的电极结构层,使尿酸测量部分不干扰血糖测量部分,同时血糖测量部分不干扰尿酸测量部分,达到可同时测量血糖和尿酸,又能保证准确度。②The uric acid electrode is combined with the blood glucose electrode using doping technology, and a unique electrode structure layer is formed through 5 precise positioning printing, so that the uric acid measurement part does not interfere with the blood glucose measurement part, and the blood glucose measurement part does not interfere with the uric acid measurement part, achieving simultaneous measurement Blood sugar and uric acid can also ensure accuracy.
附图说明Description of drawings
图1为本实用新型一实施例的血糖尿酸测试纸的结构分解图;Fig. 1 is the exploded view of the structure of the blood glucose and uric acid test paper of an embodiment of the present invention;
图2为本实用新型一实施例的血糖尿酸测试纸的电极层结构图;Fig. 2 is the electrode layer structural diagram of the blood glucose uric acid test paper of an embodiment of the present invention;
图3为本实用新型一实施例的血糖尿酸测试纸的正面图;Fig. 3 is the front view of the blood glucose and uric acid test paper of an embodiment of the present invention;
图4为本实用新型一实施例的血糖尿酸测试纸的虹吸槽剖面图。Fig. 4 is a sectional view of the siphon groove of the blood glucose and uric acid test paper according to an embodiment of the present invention.
其中,1基板、2电极层、21银浆层、22第一碳层、23氯化银电极、24第二碳层、25绝缘层、3酶层、4胶层、5亲水膜层、6虹吸槽;221血糖对电极、222血糖工作电极、241尿酸工作电极、242第一电极、243第二电极、31尿酸酶层、32血糖酶层。Among them, 1 substrate, 2 electrode layers, 21 silver paste layer, 22 first carbon layer, 23 silver chloride electrode, 24 second carbon layer, 25 insulating layer, 3 enzyme layer, 4 glue layer, 5 hydrophilic film layer, 6 siphon tank; 221 blood glucose counter electrode, 222 blood glucose working electrode, 241 uric acid working electrode, 242 first electrode, 243 second electrode, 31 uricase layer, 32 blood glucose enzyme layer.
具体实施方式Detailed ways
如图1所示,本实用新型一实施例从下至上依次包括PET基板1、电极层2、酶层3和亲水膜层5,所述胶层4环绕所述酶层3设置,所述胶层4采用双面胶层。如图2所示,其中电极层2由银浆层21、第一碳层22、氯化银电极23、第二碳层24及绝缘层25组成,并依次从下至上印刷于PET基板1上。如图3-4所示,所述的酶层3由尿酸酶层31和血糖酶层32组成,其中尿酸酶层31靠近虹吸槽6边缘,血糖酶层32位于虹吸槽6内侧;所述的虹吸槽6由PET基板1、电极层2、双面胶4和亲水膜5形成,靠虹吸孔51的虹吸作用力将血液吸入虹吸槽6,使血液中的血糖和尿酸与不同的酶层反应产生电流,其中尿酸酶层31不干扰血糖反应电流,血糖酶层32不干扰尿酸反应电流。As shown in Figure 1, an embodiment of the present invention includes a PET substrate 1, an electrode layer 2, an enzyme layer 3 and a hydrophilic film layer 5 from bottom to top, the adhesive layer 4 is arranged around the enzyme layer 3, and the Adhesive layer 4 adopts double-sided adhesive layer. As shown in Figure 2, the electrode layer 2 is composed of a silver paste layer 21, a first carbon layer 22, a silver chloride electrode 23, a second carbon layer 24 and an insulating layer 25, and is printed on the PET substrate 1 sequentially from bottom to top. . As shown in Figures 3-4, the enzyme layer 3 is composed of a uricase layer 31 and a glucose enzyme layer 32, wherein the uricase layer 31 is close to the edge of the siphon groove 6, and the glucose enzyme layer 32 is located inside the siphon groove 6; The siphon groove 6 is formed by the PET substrate 1, the electrode layer 2, the double-sided adhesive tape 4 and the hydrophilic film 5. The blood is sucked into the siphon groove 6 by the siphon force of the siphon hole 51, so that the blood sugar and uric acid in the blood are separated from the different enzyme layers. The reaction generates a current, wherein the uricase layer 31 does not interfere with the blood glucose response current, and the glucose enzyme layer 32 does not interfere with the uric acid response current.
第一碳层22由血糖对电极221和血糖工作电极222组成,形成电流回路,两个电极覆盖有血糖酶层32,用于测量血糖。The first carbon layer 22 is composed of a blood glucose counter electrode 221 and a blood glucose working electrode 222 to form a current loop. The two electrodes are covered with a glucose enzyme layer 32 for measuring blood glucose.
第二碳层24印刷有尿酸工作电极241、第一电极242及第二电极243,其中尿酸工作极241与氯化银电极23形成电流回路,用于测量尿酸,尿酸酶层31覆盖于尿酸工作电极241与氯化银电极23之间;其中第一电极242与第二电极243形成电流回路,用于测量HCT阻抗值。第二碳层24由掺杂的氧化型电子介体碳浆印刷而成,碳层厚度控制在10um~300um之间,其中氧化型电子介体为二茂铁类衍生物、四硫富瓦烯TTF类衍生物、亚甲基蓝中的一种。The second carbon layer 24 is printed with a uric acid working electrode 241, a first electrode 242, and a second electrode 243, wherein the uric acid working electrode 241 and the silver chloride electrode 23 form a current loop for measuring uric acid, and the uricase layer 31 covers the uric acid working electrode. Between the electrode 241 and the silver chloride electrode 23; wherein the first electrode 242 and the second electrode 243 form a current loop for measuring the HCT impedance value. The second carbon layer 24 is printed from doped oxidized electron mediator carbon paste, the thickness of the carbon layer is controlled between 10um and 300um, and the oxidized electron mediator is ferrocene derivatives, tetrathiafulvalene One of TTF derivatives and methylene blue.
工作时,血液被吸入虹吸槽6,由第一电极242和第二电极243组成的电导率测试电极对被吸入虹吸槽6的血液进行血细胞压积HCT的测量,而后血液先后进入尿酸电化学反应部、血糖电化学反应部,尿酸电化学反应部包括尿酸工作电极241和氯化银电极23因为所述的第二碳层24由掺杂的氧化型电子介体碳浆印刷而成,所以在尿酸酶层31不再含有电子介体,经过血液流动,不会有电子介质干扰血糖回路电流,血糖电化学反应部包括血糖对电极221和血糖工作电极222。最终在相应的测试仪上利用HCT的测试值,通过HCT对尿酸浓度、血糖浓度的影响曲线来校准尿酸测量值、血糖测量值,最终记录和显示在测试仪上。During work, the blood is sucked into the siphon tank 6, and the conductivity testing electrode composed of the first electrode 242 and the second electrode 243 measures the hematocrit HCT of the blood sucked into the siphon tank 6, and then the blood enters the uric acid electrochemical reaction successively. Section, blood glucose electrochemical reaction section, uric acid electrochemical reaction section includes uric acid working electrode 241 and silver chloride electrode 23 because the second carbon layer 24 is printed by doped oxidized electron mediator carbon paste, so in The uricase layer 31 no longer contains electron mediators, and no electron mediators will interfere with the blood sugar circuit current through the blood flow. The blood sugar electrochemical reaction part includes a blood sugar counter electrode 221 and a blood sugar working electrode 222 . Finally, use the HCT test value on the corresponding tester to calibrate the uric acid measurement value and blood glucose measurement value through the influence curve of HCT on uric acid concentration and blood sugar concentration, and finally record and display on the tester.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202320142978.6U CN219590235U (en) | 2023-02-07 | 2023-02-07 | Blood glucose uric acid test paper with red blood cell packed volume correction function |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202320142978.6U CN219590235U (en) | 2023-02-07 | 2023-02-07 | Blood glucose uric acid test paper with red blood cell packed volume correction function |
Publications (1)
Publication Number | Publication Date |
---|---|
CN219590235U true CN219590235U (en) | 2023-08-25 |
Family
ID=87696277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202320142978.6U Active CN219590235U (en) | 2023-02-07 | 2023-02-07 | Blood glucose uric acid test paper with red blood cell packed volume correction function |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN219590235U (en) |
-
2023
- 2023-02-07 CN CN202320142978.6U patent/CN219590235U/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9335291B2 (en) | Fill sufficiency method and system | |
WO2021223316A1 (en) | Preparation method for ratio electrochemical uric acid sensor based on zinc-coordinated black phosphorus nanosheet composite and bio-enzyme catalysis | |
TWI493186B (en) | Test strip, detecting device and detection method | |
KR20060089464A (en) | Electrochemical Biosensor | |
JP2008536125A (en) | Oxidizable species as an internal reference in control solutions for biosensors | |
JP2013524196A (en) | Electrochemical analyte measurement method and system | |
US20240302312A1 (en) | Electrochemical test strip for testing multiple indicators, and testing method thereof | |
JP7476215B2 (en) | A tool for the quantitative determination of cationic electrolyte and creatinine concentrations and their ratios. | |
US20240060928A1 (en) | Biosensor | |
CN103105426A (en) | Urine glucose testing method and biosensor used in method | |
CN114235925A (en) | Anti-interference electrochemical uric acid test paper and preparation method thereof | |
TWM467058U (en) | Biochemical sensor | |
CN209086198U (en) | A kind of blood glucose, the difunctional electrochemical test strip of uric acid | |
CN219590235U (en) | Blood glucose uric acid test paper with red blood cell packed volume correction function | |
CN113358726B (en) | Electrode, test paper and preparation method thereof for detecting creatinine by electrochemical method | |
CN203535003U (en) | Biosensor | |
CN118937681A (en) | A dual-channel HCT blood sugar measurement sensor and measurement method | |
CN103175871A (en) | Enzyme detection reagent of uric acid for electrochemical test strip | |
CN100392389C (en) | Electrochemical sensing test piece | |
TW201719161A (en) | System and method for compensating sample-related measurements based on polarization effects of test strips | |
CN215493305U (en) | Electrodes, test strips and biosensors for electrochemical detection of creatinine | |
CN116359306A (en) | Human blood glucose sensor with high area utilization rate and preparation method thereof | |
CN210665581U (en) | Electrochemical test strip with dual functions of blood sugar and blood ketone | |
CN204718995U (en) | Detect the bio-sensing electrode of Blood Trace signal | |
JP3117103U (en) | Electrochemical biological specimen that can be sampled in a small amount |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant |